J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per Company s code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company will remain closed from April 1, 2017 and will re-open on May 29, 2017 in connection with consideration and approval of the audited accounts for the financial year ending on March 31, 2017 by the Board of Directors of the Company.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per Company s code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company will remain closed from January 1, 2017 and will re-open on February 15, 2017 in connection with consideration and approval of unaudited financial results for the quarter ending on December 31, 2016 by the Board of Directors of the Company.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Corporate office and future Communication address of the Company now is as under: J. B. CHEMICALS & PHARMACEUTICALS LIMITED Cnergy IT Park, Unit A2, 3rd Floor, Appa Saheb Marathe Marg, Prabhadevi Mumbai 400 025 Phone: +91 22 2439 5200 / 2439 5500

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per Companys code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company will remain closed from October 1, 2016 and will re-open on November 23, 2016 in connection with consideration and approval of unaudited financial results for the quarter ending on September 30, 2016 by the Board of Directors of the Company.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per company s code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the company will remain closed from July 1, 2016 in connection with declaration of the unaudited financial results for the quarter ending on June 30, 2016 by the board of directors of the company. The opening of trading window will be intimated to the designated persons after the board meeting date for declaration of said results is finalized.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per company s code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the company will remain closed from April 1, 2016 in connection with declaration of the audited financial results for the quarter/year ended on March 31, 2016 by the board of directors of the company. The opening of trading window will be intimated to the designated persons after the board meeting date for declaration of said results is finalized.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per company's code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the company will remain closed from March 2, 2016 to March 15, 2016 (both days inclusive) in connection with the consideration and declaration of interim dividend by the board of directors of the company at its meeting to be held on March 11, 2016.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the trading window for dealing in the securities of the company will remain closed from January 1, 2016 in connection with declaration of the unaudited financial results for the quarter ending on December 31, 2015.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange the trading window for dealing in the securities of the company stands closed from October 1, 2015 until further notice in connection with declaration of unaudited financial results for the quarter ended on September 30, 2015.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per company s code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the company will remain closed from July 1, 2015 to August 9, 2015 (both days inclusive) in connection with declaration of unaudited financial results for the quarter ended on June 30, 2015.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Pursuant to Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, Code of practices and procedures for fair disclosure of Unpublished Price Sensitive Information formulated and approved by the board of directors of the company at its meeting held on May 20, 2015.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per company's code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 1992, the trading window for dealing in the securities of the company will remain closed for all the directors/designated employees of the company from April 1, 2015 to May 24, 2015 (both days inclusive) in connection with declaration of the audited financial results for the quarter/year ending on March 31, 2015. This closure of trading window has already been notified to all the directors/ designated employees.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that as per company's code of conduct framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 1992, the trading window for dealing in the securities of the company will remain closed for all the directors/designated employees of the company from January 1, 2015 to February 8, 2015 (both days inclusive) in connection with approval of the unaudited financial results for the quarter ending on December 31, 2014. This closure of trading window has already been notified to all the directors/ designated employees.